During the procedure, the patient is given a low dose of insulin to lower blood sugar levels, followed by a reduced dose of chemotherapy drugs. The theory is that the lower levels of blood sugar will cause cancer cells to become more sensitive to chemotherapy, making the treatment more effective while reducing the risk of side effects.